Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Sangamo BioSciences, Inc. (SGMO)

« Back to company index

SGMO Chatter Timeline

Stock Ticker for SGMO

Most Active Tweeters for SGMO

UserTweets
@_B_I_O_T_E_C_H_ 30
@JustTradingHoy 13
@Jdalexander64 11
@mchilberg 9
@1MinuteStock 9

Recent Tweets for SGMO

bulletin_en @bulletin_en
Five Prime Therapeutics Inc. $SGMO https://t.co/z1Qh6VWQks
May 23rd 2019, 5:05pm
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $9.74) was this week's top stock market loser, declining -5% https://t.co/kEs2Z2SExJ
May 23rd 2019, 3:05pm
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $9.74) was the stock market's top loser yesterday, falling -3.37% https://t.co/yMgrKkIsPV
May 23rd 2019, 3:05pm
Jdalexander64 @Jdalexander64
@ByMadeleineA @Vantageanalysis Yes, only two patients in $SGMO $PFE data but at the end of the day, there will only… https://t.co/garHzRh9bH
May 23rd 2019, 1:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @mchilberg: $SGMO beginning to ramp conversation about #Fabry gene therapy program with clinical initiation expected in 2H19 'excited' a…
May 23rd 2019, 12:05pm
Jaytanoo @Jaytanoo
$SGMO MAN O MAN THIS IS DOWN ON NOTHING.. GOING INTO A 3 DAY WEEKEND WITH MARKET WEAKNESS - IF THEY GET THIS TO $9… https://t.co/YkwawhWnPR
May 23rd 2019, 12:05pm
mchilberg @mchilberg
$SGMO beginning to ramp conversation about #Fabry gene therapy program with clinical initiation expected in 2H19 'e… https://t.co/7iRDJeFXBA
May 23rd 2019, 11:05am
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $9.74) was the month's biggest loser, shedding -17% https://t.co/yn5Y8cc90W
May 23rd 2019, 11:05am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: $PFE says on $SGMO partnership "So that allowed us to keep a lot of fire power for #additional programs while #nurturi…
May 23rd 2019, 7:05am
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $10.08) was the market's top quarterly gainer, rising +19% https://t.co/9QJs1RksFs
May 22nd 2019, 3:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$PFE says on $SGMO partnership "So that allowed us to keep a lot of fire power for #additional programs while… https://t.co/2YyqWudsNJ
May 22nd 2019, 2:05pm
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $10.08) was the market's top winner yesterday, jumping +3.07% https://t.co/5PLVNmpSNy
May 22nd 2019, 8:05am
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $10.08) was the month's biggest loser, shedding -14% https://t.co/LvWDz3sqeV
May 22nd 2019, 6:05am
BehaviorFin @BehaviorFin
FINAL RESULT After latest studies and discussions, which is the main issue of #MPS2 #geneediting trial by $SGMO?… https://t.co/JtwQStSIu7
May 22nd 2019, 3:05am
BehaviorFin @BehaviorFin
FINAL RESULT If biotech big caps and Big Pharma, $SGMO Which might be new buyers at last week's stock offering amon… https://t.co/g0RaoumsHf
May 22nd 2019, 3:05am
BehaviorFin @BehaviorFin
FINAL RESULT Why don't we hear news on #Huntington 's disease in #genetherapy #geneediting from $SGMO's partner… https://t.co/GehAWCmSGz
May 22nd 2019, 3:05am
BehaviorFin @BehaviorFin
FINAL RESULT If we heard news on #Huntington 's disease in #genetherapy #geneediting by $SGMO's partner #SHPG… https://t.co/3Tdet9MaOQ
May 22nd 2019, 3:05am
Tickeron @Tickeron
$SGMO Sangamo Therapeutics (SGMO, $9.78) was the month's biggest loser, shedding -16% https://t.co/f8kFXz76cg
May 22nd 2019, 1:05am
skumar22italy @skumar22italy
RT @_B_I_O_T_E_C_H_: $SGMO @ CNBC future of genetic medicines https://t.co/1yWLY5rfJK
May 21st 2019, 6:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO @ CNBC future of genetic medicines https://t.co/1yWLY5rfJK
May 21st 2019, 3:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
hearing $SGMO gets mention on #CNBC
May 21st 2019, 3:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: $SGMO has been granted #Patent 10,293,000 May 21, 2019 Methods and compositions for the treatment of…
May 21st 2019, 3:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: Sangamo $SGMO beta thalassemia clinical trial update ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (T…
May 21st 2019, 3:05pm
Jaytanoo @Jaytanoo
@_B_I_O_T_E_C_H_ $SGMO COME ON BABY ... $10 BUCKS IS ABSURDLY CHEAP
May 21st 2019, 1:05pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
Sangamo $SGMO beta thalassemia clinical trial update ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia… https://t.co/0jsaDcHj7j
May 21st 2019, 1:05pm
tymax521 @tymax521
$SGMO Bounce bitch lol..
May 21st 2019, 10:05am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO has been granted #Patent 10,293,000 May 21, 2019 Methods and compositions for the treatment… https://t.co/snHz48bpkI
May 21st 2019, 3:05am
Jaytanoo @Jaytanoo
$SGMO OK AFTER A FEW WEEKS OFF FOR MENTAL HEALTH TIME IM BACK !! WHATS UP HERE WHY THE WEAKNESS >>
May 20th 2019, 11:05am
bulletin_en @bulletin_en
Granahan Investment Management Lowered Sangamo Biosciences $SGMO Stake By $431,750; Ranger Investment Management LP… https://t.co/ksiQxqXQsj
May 20th 2019, 10:05am
MACDcurlingup @MACDcurlingup
I believe in Sandy! $SGMO https://t.co/gmTgspgNvO
May 20th 2019, 10:05am
AmericanBanking @AmericanBanking
Sangamo Therapeutics Inc $SGMO Given Average Recommendation of “Buy” by Brokerages https://t.co/zXmNHNxaQ7 #stocks
May 20th 2019, 10:05am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @wyv_123: $SGMO not a sponsor last year, neither was Roche. Don't know how they got a link for $RHHBY this year. Incorrect link referenc…
May 20th 2019, 1:05am
wyv_123 @wyv_123
$SGMO not a sponsor last year, neither was Roche. Don't know how they got a link for $RHHBY this year. Incorrect li… https://t.co/UTLTsaFPG8
May 19th 2019, 9:05pm
MACDcurlingup @MACDcurlingup
@TheMarketsDaily This individual has resigned! $SGMO
May 19th 2019, 3:05pm
StockRatingsHQ @StockRatingsHQ
RT @StockWatchHQ: Following Downgrade Sangamo Therapeutics $SGMO Assessing New Acquisition Offer From Gilead Sciences $GILD In Foster City,…
May 19th 2019, 1:05pm
bbnsnews @bbnsnews
Sangamo Therapeutics Inc $SGMO CFO Sells $50,000.00 in Stock https://t.co/hZ1946C13m
May 19th 2019, 10:05am
YMuer @YMuer
RT @MaxPowerNGS: $SGMO @SangamoTx still hasn’t corrected the incorrect sponsorship link for the conference they paid to sponsor. When you c…
May 19th 2019, 8:05am
dakotafinancial @dakotafinancial
Sangamo Therapeutics Inc $SGMO Expected to Earn Q2 2019 Earnings of -$0.18 Per Share https://t.co/KDWhNn8nlO
May 19th 2019, 1:05am
bulletin_en @bulletin_en
Comparing of Prana Biotechnology Limited $SGMO https://t.co/RzBCiJVSC5
May 18th 2019, 7:05pm
MaxPowerNGS @MaxPowerNGS
$SGMO @SangamoTx still hasn’t corrected the incorrect sponsorship link for the conference they paid to sponsor. Whe… https://t.co/RbEuK2Gj0J
May 18th 2019, 7:05pm
StockWatchHQ @StockWatchHQ
Following Downgrade Sangamo Therapeutics $SGMO Assessing New Acquisition Offer From Gilead Sciences $GILD In Foster… https://t.co/lDfPXDgMx7
May 18th 2019, 7:05pm
TheMarketsDaily @TheMarketsDaily
Insider Selling: Sangamo Therapeutics Inc $SGMO CFO Sells 5,000 Shares of Stock https://t.co/FUnVpSOqX9
May 18th 2019, 3:05pm
insearchofdelta @insearchofdelta
New $SGMO job posting. https://t.co/hIHqUFc7gf
May 18th 2019, 2:05pm
McBurnMark @McBurnMark
RT @wyv_123: Never a dull moment with $SGMO. All the other company sponsor links work correctly. Sangamo's link goes to Roche $RHHBY. Very…
May 18th 2019, 12:05pm
wyv_123 @wyv_123
Never a dull moment with $SGMO. All the other company sponsor links work correctly. Sangamo's link goes to Roche… https://t.co/XkuXbBJmL6
May 18th 2019, 11:05am
Abby10Smalls @Abby10Smalls
@_B_I_O_T_E_C_H_ So it’s not just about a therapy but a platform? Hmmmm. $SGMO.
May 18th 2019, 7:05am
TranscriptDaily @TranscriptDaily
Sangamo Therapeutics $SGMO Given a $11.00 Price Target at Wedbush https://t.co/cD6i8p86ha
May 18th 2019, 3:05am
OlympiaReport @OlympiaReport
Sangamo Therapeutics $SGMO Given a $11.00 Price Target at Wedbush https://t.co/NTRLicf2VW
May 18th 2019, 3:05am
ThisLincolnian @ThisLincolnian
Q2 2019 EPS Estimates for Sangamo Therapeutics Inc $SGMO Lowered by Analyst https://t.co/zTA0jzd67h
May 18th 2019, 1:05am
AmericanBanking @AmericanBanking
Kathy Yi Sells 5,000 Shares of Sangamo Therapeutics Inc $SGMO Stock https://t.co/oQFZQ4CMki #stocks
May 17th 2019, 9:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.